I write to you as director of finance, insurance and trade policy for the R Street Institute, a nonprofit, nonpartisan public-policy research organization whose mission is to engage in policy…

IN RE: MOTION FOR COMMISSION CALLED HEARING ON THE VERIFIED COMPLAINT OF PIONEER NATURAL RESOURCES U.S.A. INC. AND PARSLEY ENERGY INC. TO DETERMINE REASONABLE MARKET DEMAND FOR OIL IN THE STATE OF…

Written testimony of M. Anthony Mills, director of science policy, R Street Institute
Submitted to the U.S. House of Representatives, Committee on Appropriations,
Subcommittee on the Legislative…

Testimony from:
Courtney Joslin, Commercial Freedom Fellow, R Street Institute
Testimony in Support of SF 1960
March 12, 2020
Minnesota State Senate, Health and Human Services Finance and Policy…

Testimony from:
Anthony Lamorena, Government Affairs Associate, R Street Institute
In OPPOSITION to HB 2457, “RELATING TO THE YOUTH VAPING EPIDEMIC”
March 11, 2020
Senate Commerce, Consumer…

Testimony from:
Chelsea Boyd, Harm Reduction Policy Research Associate, R Street Institute
In OPPOSITION to HB 5020, “AN ACT IMPLEMENTING THE GOVERNOR’S BUDGET RECOMMENDATIONS REGARDING PUBLIC…

Written testimony of Kevin R. Kosar
Vice President of Research Partnerships, R Street Institute
Before the U.S. House of Representatives,
Committee on Appropriations,
Legislative Branch…

Testimony from:
Jesse Kelley, Government Affairs Manager, Criminal Justice & Civil Liberties, R Street Institute
Regarding HOUSE BILL 1209, “AN ACT AN ACT concerning Public Safety – DNA…

Testimony from:
Marc Hyden, Director of State Government Affairs, R Street Institute
Testimony on HB 879, “AN ACT to amend Article 1 of Chapter 3 of Title 3 of the O.C.G.A., relating to…

Testimony from:
Carrie Wade, Director of Harm Reduction Policy, R Street Institute
In OPPOSITION to Bill 23-0453, “Flavored Electronic Smoking Device Prohibition Amendment Act…